These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 17936901)

  • 1. Flow cytometric parameters with little interexaminer variability for diagnosing low-grade myelodysplastic syndromes.
    Satoh C; Dan K; Yamashita T; Jo R; Tamura H; Ogata K
    Leuk Res; 2008 May; 32(5):699-707. PubMed ID: 17936901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic flow cytometry for low-grade myelodysplastic syndromes.
    Ogata K
    Hematol Oncol; 2008 Dec; 26(4):193-8. PubMed ID: 18412289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometry in myelodysplastic syndrome: analysis of diagnostic utility using maturation pattern-based and quantitative approaches.
    Chopra A; Pati H; Mahapatra M; Mishra P; Seth T; Kumar S; Singh S; Pandey S; Kumar R
    Ann Hematol; 2012 Sep; 91(9):1351-62. PubMed ID: 22526362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometric chemosensitivity analysis of blasts from patients with acute myeloblastic leukemia and myelodysplastic syndromes: the use of 7AAD with antibodies to CD45 or CD34.
    Pallis M; Syan J; Russell NH
    Cytometry; 1999 Dec; 37(4):308-13. PubMed ID: 10547616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral blood MDS score: a new flow cytometric tool for the diagnosis of myelodysplastic syndromes.
    Cherian S; Moore J; Bantly A; Vergilio JA; Klein P; Luger S; Bagg A
    Cytometry B Clin Cytom; 2005 Mar; 64(1):9-17. PubMed ID: 15668954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revising flow cytometric mini-panel for diagnosing low-grade myelodysplastic syndromes: Introducing a parameter quantifying CD33 expression on CD34+ cells.
    Ogata K; Sei K; Saft L; Kawahara N; Porta MGD; Chapuis N; Yamamoto Y
    Leuk Res; 2018 Aug; 71():75-81. PubMed ID: 30025279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow cytometric scoring system (FCMSS) assisted diagnosis of myelodysplastic syndromes (MDS) and the biological significance of FCMSS-based immunophenotypes.
    Xu F; Li X; Wu L; He Q; Zhang Z; Chang C
    Br J Haematol; 2010 May; 149(4):587-97. PubMed ID: 20331463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined flow cytometric assessment of CD45, HLA-DR, CD34, and CD117 expression is a useful approach for reliable quantification of blast cells in myelodysplastic syndromes.
    Sandes AF; Kerbauy DM; Matarraz S; Chauffaille Mde L; López A; Orfao A; Yamamoto M
    Cytometry B Clin Cytom; 2013 May; 84(3):157-66. PubMed ID: 23475532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A combination of CD15/CD10, CD64/CD33, CD16/CD13 or CD11b flow cytometric granulocyte panels is sensitive and specific for diagnosis of myelodysplastic syndrome.
    Chung JW; Park CJ; Cha CH; Cho YU; Jang S; Chi HS; Seo EJ; Lee JH; Lee JH; Lee KH; Im HJ; Seo JJ
    Ann Clin Lab Sci; 2012; 42(3):271-80. PubMed ID: 22964615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maturation-associated immunophenotypic abnormalities in bone marrow B-lymphocytes in myelodysplastic syndromes.
    Ribeiro E; Matarraz Sudón S; de Santiago M; Lima CS; Metze K; Giralt M; Saad ST; de Matos AO; Lorand-Metze I
    Leuk Res; 2006 Jan; 30(1):9-16. PubMed ID: 16005514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic application of flow cytometric characteristics of CD34+ cells in low-grade myelodysplastic syndromes.
    Ogata K; Kishikawa Y; Satoh C; Tamura H; Dan K; Hayashi A
    Blood; 2006 Aug; 108(3):1037-44. PubMed ID: 16574954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of Quantitative assessment of Myeloid Nuclear Differentiation Antigen expression and other flow cytometric parameters in the diagnosis of Myelodysplastic syndrome.
    Somasundaram V; Soni S; Chopra A; Rai S; Mahapatra M; Kumar R; Pati H
    Int J Lab Hematol; 2016 Apr; 38(2):141-50. PubMed ID: 26822549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of CD7 and terminal deoxynucleotidyl transferase (TdT) expression in CD34+ myeloblasts from patients with myelodysplastic syndrome.
    Font P; Subirá D; Mtnez-Chamorro C; Castañón S; Arranz E; Ramiro S; Gil-Fernández JJ; López-Pascual J; Alonso A; Pérez-Sáenz MA; Alaez C; Renedo M; Blas C; Escudero A; Fdez-Rañada JM
    Leuk Res; 2006 Aug; 30(8):957-63. PubMed ID: 16417922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flow cytometric evaluation of circulating CD34+ cell counts and apoptotic rate in children with acquired aplastic anemia and myelodysplasia.
    Timeus F; Crescenzio N; Doria A; Foglia L; Linari A; Giaccone M; Pastore G; di Montezemolo LC; Ramenghi U; Saracco P
    Exp Hematol; 2005 May; 33(5):597-604. PubMed ID: 15850838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Four-color flow cytometric immunophenotypic features of blasts in myelodysplastic syndromes].
    Wu YJ; Li JY; Qiu HR; Xiao B; Zhang JF; Song JH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Feb; 14(1):50-3. PubMed ID: 16584591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiparameter flow cytometric analysis reveals low percentage of bone marrow hematogones in myelodysplastic syndromes.
    Maftoun-Banankhah S; Maleki A; Karandikar NJ; Arbini AA; Fuda FS; Wang HY; Chen W
    Am J Clin Pathol; 2008 Feb; 129(2):300-8. PubMed ID: 18208811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of flow cytometric immunophenotyping in diagnosis of myelodysplastic syndromes--review].
    Zhang Y; Li X
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Dec; 16(6):1477-81. PubMed ID: 19099668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value of maturation-associated phenotypic abnormalities in myelodysplastic syndromes.
    Lorand-Metze I; Califani SM; Ribeiro E; Lima CS; Metze K
    Leuk Res; 2008 Feb; 32(2):211-3. PubMed ID: 17675154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced pediatric myelodysplastic syndromes: can immunophenotypic characterization of blast cells be a diagnostic and prognostic tool?
    Veltroni M; Sainati L; Zecca M; Fenu S; Tridello G; Testi AM; Merlone AD; Buldini B; Leszl A; Lo Nigro L; Longoni D; Bernini G; Basso G;
    Pediatr Blood Cancer; 2009 Mar; 52(3):357-63. PubMed ID: 19061215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometric analysis of myelomonocytic cells by a pattern recognition approach is sensitive and specific in diagnosing myelodysplastic syndrome and related marrow diseases: emphasis on a global evaluation and recognition of diagnostic pitfalls.
    Stachurski D; Smith BR; Pozdnyakova O; Andersen M; Xiao Z; Raza A; Woda BA; Wang SA
    Leuk Res; 2008 Feb; 32(2):215-24. PubMed ID: 17675229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.